Evotec Appoints Dr. Sarah Fakih as EVP of Global Communications and Investor Relations

Evotec SE has announced the appointment of Dr. Sarah Fakih as Executive Vice President, Head of Global Communications and Investor Relations. Dr. Fakih will oversee the newly integrated communications and investor relations function, aimed at enhancing strategic messaging and stakeholder engagement. She succeeds Volker Braun, who led the investor relations and ESG functions for five years.

Dr. Fakih has over 15 years of experience in life sciences, having held senior roles at companies such as QIAGEN, MorphoSys, and CureVac. Her expertise in capital markets strategy and corporate messaging is expected to provide significant value to Evotec. Reporting directly to CEO Dr. Christian Wojczewski, Dr. Fakih will focus on ensuring clarity and engagement across various stakeholders.